Cargando…

Adherence to the GOLD Guidelines in Primary Care: Data from the Swiss COPD Cohort

(1) Introduction: Chronic obstructive pulmonary disease (COPD) and its associated morbidity and mortality are a global burden on both affected patients and healthcare systems. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) issues guidelines with the aim of improving COPD managemen...

Descripción completa

Detalles Bibliográficos
Autores principales: Mangold, Veronika, Boesing, Maria, Berset, Camille, Bridevaux, Pierre-Olivier, Geiser, Thomas, Joos Zellweger, Ladina, Kohler, Malcolm, Lüthi-Corridori, Giorgia, Maier, Sabrina, Miedinger, David, Thurnheer, Robert, von Garnier, Christophe, Leuppi, Jörg Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607923/
https://www.ncbi.nlm.nih.gov/pubmed/37892775
http://dx.doi.org/10.3390/jcm12206636
_version_ 1785127657578430464
author Mangold, Veronika
Boesing, Maria
Berset, Camille
Bridevaux, Pierre-Olivier
Geiser, Thomas
Joos Zellweger, Ladina
Kohler, Malcolm
Lüthi-Corridori, Giorgia
Maier, Sabrina
Miedinger, David
Thurnheer, Robert
von Garnier, Christophe
Leuppi, Jörg Daniel
author_facet Mangold, Veronika
Boesing, Maria
Berset, Camille
Bridevaux, Pierre-Olivier
Geiser, Thomas
Joos Zellweger, Ladina
Kohler, Malcolm
Lüthi-Corridori, Giorgia
Maier, Sabrina
Miedinger, David
Thurnheer, Robert
von Garnier, Christophe
Leuppi, Jörg Daniel
author_sort Mangold, Veronika
collection PubMed
description (1) Introduction: Chronic obstructive pulmonary disease (COPD) and its associated morbidity and mortality are a global burden on both affected patients and healthcare systems. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) issues guidelines with the aim of improving COPD management. Previous studies reported significant variability in adherence to these recommendations. The objective of this study was to evaluate Swiss primary practitioners’ adherence to the GOLD guidelines for the pharmacological treatment of stable COPD. (2) Methods: We studied patients who were included in the Swiss COPD cohort study, an ongoing prospective study in a primary care setting, between 2015 and 2022. The key inclusion criteria are age ≥ 40 years, FEV1/FVC ratio < 70%, and a smoking history of at least 20 pack-years. Adherence to the GOLD guidelines was assessed per visit and over time. (3) Results: The data of 225 COPD patients (mean age 67 ± 9 years, 64% male) and their respective 1163 visits were analyzed. In 65% of visits (726/1121), treatment was prescribed according to the GOLD guidelines. Non-adherence was most common in GOLD groups A and B (64% and 33%) and mainly consisted of over-treatment (two long-acting bronchodilators in group A (98/195, 50%) and ICS in groups A (21/195, 11%) and B (198/808, 25%)). In group D, the prescriptions conformed with the guidelines in 99% of cases (109/108). Guideline adherence was associated with high symptom load (COPD Assessment Test) (OR 1.04, p = 0.002), high number of exacerbations (OR = 2.07, p < 0.001), asthma overlap (OR 3.36, p = 0.049), and diabetes mellitus (OR 2.82, p = 0.045). (4) Conclusion: These results confirm a conflict between the GOLD recommendations and primary practice, mainly concerning over-treatment in GOLD groups A and B. Patients with high symptom load, high exacerbation risk, asthma overlap, and diabetes mellitus are more likely to be treated in conformity with the guidelines. Further research is needed to uncover the reasons for the discrepancies and to design strategies for improvement.
format Online
Article
Text
id pubmed-10607923
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106079232023-10-28 Adherence to the GOLD Guidelines in Primary Care: Data from the Swiss COPD Cohort Mangold, Veronika Boesing, Maria Berset, Camille Bridevaux, Pierre-Olivier Geiser, Thomas Joos Zellweger, Ladina Kohler, Malcolm Lüthi-Corridori, Giorgia Maier, Sabrina Miedinger, David Thurnheer, Robert von Garnier, Christophe Leuppi, Jörg Daniel J Clin Med Article (1) Introduction: Chronic obstructive pulmonary disease (COPD) and its associated morbidity and mortality are a global burden on both affected patients and healthcare systems. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) issues guidelines with the aim of improving COPD management. Previous studies reported significant variability in adherence to these recommendations. The objective of this study was to evaluate Swiss primary practitioners’ adherence to the GOLD guidelines for the pharmacological treatment of stable COPD. (2) Methods: We studied patients who were included in the Swiss COPD cohort study, an ongoing prospective study in a primary care setting, between 2015 and 2022. The key inclusion criteria are age ≥ 40 years, FEV1/FVC ratio < 70%, and a smoking history of at least 20 pack-years. Adherence to the GOLD guidelines was assessed per visit and over time. (3) Results: The data of 225 COPD patients (mean age 67 ± 9 years, 64% male) and their respective 1163 visits were analyzed. In 65% of visits (726/1121), treatment was prescribed according to the GOLD guidelines. Non-adherence was most common in GOLD groups A and B (64% and 33%) and mainly consisted of over-treatment (two long-acting bronchodilators in group A (98/195, 50%) and ICS in groups A (21/195, 11%) and B (198/808, 25%)). In group D, the prescriptions conformed with the guidelines in 99% of cases (109/108). Guideline adherence was associated with high symptom load (COPD Assessment Test) (OR 1.04, p = 0.002), high number of exacerbations (OR = 2.07, p < 0.001), asthma overlap (OR 3.36, p = 0.049), and diabetes mellitus (OR 2.82, p = 0.045). (4) Conclusion: These results confirm a conflict between the GOLD recommendations and primary practice, mainly concerning over-treatment in GOLD groups A and B. Patients with high symptom load, high exacerbation risk, asthma overlap, and diabetes mellitus are more likely to be treated in conformity with the guidelines. Further research is needed to uncover the reasons for the discrepancies and to design strategies for improvement. MDPI 2023-10-20 /pmc/articles/PMC10607923/ /pubmed/37892775 http://dx.doi.org/10.3390/jcm12206636 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Mangold, Veronika
Boesing, Maria
Berset, Camille
Bridevaux, Pierre-Olivier
Geiser, Thomas
Joos Zellweger, Ladina
Kohler, Malcolm
Lüthi-Corridori, Giorgia
Maier, Sabrina
Miedinger, David
Thurnheer, Robert
von Garnier, Christophe
Leuppi, Jörg Daniel
Adherence to the GOLD Guidelines in Primary Care: Data from the Swiss COPD Cohort
title Adherence to the GOLD Guidelines in Primary Care: Data from the Swiss COPD Cohort
title_full Adherence to the GOLD Guidelines in Primary Care: Data from the Swiss COPD Cohort
title_fullStr Adherence to the GOLD Guidelines in Primary Care: Data from the Swiss COPD Cohort
title_full_unstemmed Adherence to the GOLD Guidelines in Primary Care: Data from the Swiss COPD Cohort
title_short Adherence to the GOLD Guidelines in Primary Care: Data from the Swiss COPD Cohort
title_sort adherence to the gold guidelines in primary care: data from the swiss copd cohort
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607923/
https://www.ncbi.nlm.nih.gov/pubmed/37892775
http://dx.doi.org/10.3390/jcm12206636
work_keys_str_mv AT mangoldveronika adherencetothegoldguidelinesinprimarycaredatafromtheswisscopdcohort
AT boesingmaria adherencetothegoldguidelinesinprimarycaredatafromtheswisscopdcohort
AT bersetcamille adherencetothegoldguidelinesinprimarycaredatafromtheswisscopdcohort
AT bridevauxpierreolivier adherencetothegoldguidelinesinprimarycaredatafromtheswisscopdcohort
AT geiserthomas adherencetothegoldguidelinesinprimarycaredatafromtheswisscopdcohort
AT jooszellwegerladina adherencetothegoldguidelinesinprimarycaredatafromtheswisscopdcohort
AT kohlermalcolm adherencetothegoldguidelinesinprimarycaredatafromtheswisscopdcohort
AT luthicorridorigiorgia adherencetothegoldguidelinesinprimarycaredatafromtheswisscopdcohort
AT maiersabrina adherencetothegoldguidelinesinprimarycaredatafromtheswisscopdcohort
AT miedingerdavid adherencetothegoldguidelinesinprimarycaredatafromtheswisscopdcohort
AT thurnheerrobert adherencetothegoldguidelinesinprimarycaredatafromtheswisscopdcohort
AT vongarnierchristophe adherencetothegoldguidelinesinprimarycaredatafromtheswisscopdcohort
AT leuppijorgdaniel adherencetothegoldguidelinesinprimarycaredatafromtheswisscopdcohort